255 related articles for article (PubMed ID: 1378075)
1. Soluble forms of CD40 inhibit biologic responses of human B cells.
Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
3. Identification of a source of biologically active CD40 ligand.
Armitage RJ; Sato TA; Macduff BM; Clifford KN; Alpert AR; Smith CA; Fanslow WC
Eur J Immunol; 1992 Aug; 22(8):2071-6. PubMed ID: 1379186
[TBL] [Abstract][Full Text] [Related]
4. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
Zhang K; Clark EA; Saxon A
J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory role of CD40 in human B cell differentiation.
Splawski JB; Fu SM; Lipsky PE
J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
[TBL] [Abstract][Full Text] [Related]
7. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
8. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40.
Diaz-Sanchez D; Chegini S; Zhang K; Saxon A
J Immunol; 1994 Jul; 153(1):10-20. PubMed ID: 7515920
[TBL] [Abstract][Full Text] [Related]
9. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.
Kwekkeboom J; De Boer M; Tager JM; De Groot C
Immunology; 1993 Jul; 79(3):439-44. PubMed ID: 7691726
[TBL] [Abstract][Full Text] [Related]
10. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
Luo HY; Hofstetter H; Banchereau J; Delespesse G
J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
[TBL] [Abstract][Full Text] [Related]
11. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
[TBL] [Abstract][Full Text] [Related]
12. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
Gordon J; Katira A; Strain AJ; Gillis S
Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
[TBL] [Abstract][Full Text] [Related]
14. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
[TBL] [Abstract][Full Text] [Related]
15. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
Wheeler K; Pound JD; Gordon J; Jefferis R
Eur J Immunol; 1993 May; 23(5):1165-8. PubMed ID: 7682959
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to distinct epitopes on the CD40 molecule co-operate in stimulation and can be used for the detection of soluble CD40.
Björck P; Braesch-Andersen S; Paulie S
Immunology; 1994 Nov; 83(3):430-7. PubMed ID: 7530692
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
Santos-Argumedo L; Gordon J; Heath AW; Howard M
Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
[TBL] [Abstract][Full Text] [Related]
18. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
[TBL] [Abstract][Full Text] [Related]
19. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.
Gordon J; Millsum MJ; Flores-Romo L; Gillis S
Immunology; 1989 Dec; 68(4):526-31. PubMed ID: 2481643
[TBL] [Abstract][Full Text] [Related]
20. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
